FDA Approved Many New Drugs in 2022 That Will Improve the Lives of Patients and Consumers

Bristol Myers Squibb immunotherapy-chemo combination gets NICE recommendation

On a roll, Takeda's dengue vaccine shifts into FDA's fast review lane

FDA panel votes in favor of Ardelyx’s once-rejected kidney disease drug.

FDA halts Verve plans to test gene editing therapy for heart disease in US.

Abeona to submit cell therapy for approval after positive results for skin disorder treatment

EMA looks to follow the FDA in limiting use of certain immune-regulating drugs

FDA rejects Supernus’ drug infusion device for Parkinson’s

Pfizer, BioNTech seek FDA clearance for updated COVID-19 booster in children